Company* (Country; Symbol)

Company* (Country; Symbol)

Product

Terms/Details (Date)


Affymetrix
Inc.
(AFFX)

Ingenuity Systems*

Ingenuity Pathways Analysis product

Ingenuity will deliver the product to Affymetrix customers; Affymetrix made an undisclosed equity investment in Ingenuity (8/11)

  

Akers
Biosciences
Inc. (LSE:AKR)

The Medicines Co. (MDCO)

Akers' Rapid HeparinPlatelet  Factor-4 antibody test

The Medicines Co. will increase awareness and market the test once it receives regulatory approval (7/2)

  

Amphioxus
Cell Technologies*

Pierce Inc.*

Products used in the sequential process of target identification and validation specific to kinases, phosphatases and ADME-TOX

Companies formed a co-marketing agreement for the Pierce IQ Kinase Assay Platform and the ACTIV-Tox Drug Discovery Platform of Amphioxus Cell (8/13)

 

Cobra Biomanufacturing (UK;LSE:CBF)

Advaxis Inc.*

Listeria monocytogenes-based cancer vaccine's active ingredient

Cobra won a contract to supply the active ingredient for a Listeria monocytogenes-based cancer vaccine to Advaxis (8/6**)

 

Corixa
Corp.
(CRXA)

Meridian Bioscience Inc. (VIVO)

A recombinant Trypanosoma cruzi (Chagas' disease) antigen

Meridian is producing the antigen at its laboratories located at Viral Antigens Inc.; the antigen known as TcF will be marketed to diagnostic test manufacturers for use in production of test kits for blood bank screening and other diagnostic applications (7/21)

 

Incyte
Corp.
(INCY)

Linden
Bioscience*
(division of
Linden Technologies
Inc.)

Amplification kits for research use

Linden will manufacture and sell the kits for research use directed to linear mRNA amplification technology exclusively licensed to Incyte (7/7)

 

Lonza
Biologics
plc* (UK)

Vaccinex Inc.*

Recombinant proteins and antibody products

Lonza will provide Vaccinex, its clients and partners with access to its Glutamine  Synthetase Gene Expression system; Lonza also will provide access to its cGMP manu- facturing facilities for the clinical pro- duction of recombinant proteins and anti-body products (7/11)

 

MDS Sciex
(division of MDS
Inc.; Canada; NYSE:MDZ; TSE:MDS)

LEAP Technologies
Inc.*

NanoLC proteomics system

LEAP will distribute the new NanoLC proteomics system in the U.S. (8/5)

 

Progenitor Cell Therapy LLC*

Proneuron Biotechnologies Inc.*

Clinical trial-grade human cells

Progenitor Cell will manufacture auto- logous cells for evaluating therapeutic efficacy in patients with recent spinal cord damage, using Proneuron's ProCord technology (6/25)

 

Qiagen NV (the Netherlands; QGENF)

Intradigm Corp.*

Small interfering RNA

Qiagen will manufacture and provide Intradigm with siRNA agents for research programs in several disease areas, including oncology, arthritis and severe acute respiratory syndrome coronavirus infection (7/8)


Notes:

# The information in the chart does not cover agricultural agreements.

* Private companies are indicated with an asterisk. ** Denotes the date the item ran in BioWorld International.

Unless otherwise noted, stock symbols listed are on the Nasdaq market.

LSE = London Stock Exchange; NYSE = New York Stock Exchange; TSE = Toronto Stock Exchange.

No Comments